Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia - PubMed (original) (raw)

Affiliations

PMID: 15656713

Clinical Trial

Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia

Ruxandra Bunea et al. Altern Med Rev. 2004 Dec.

Abstract

Objective: To assess the effects of krill oil on blood lipids, specifically total cholesterol, triglycerides, low-density lipoprotein (LDL), and high-density lipoprotein (HDL).

Methods: A multi-center, three-month, prospective, randomized study followed by a three-month, controlled follow-up of patients treated with 1 g and 1.5 g krill oil daily. Patients with hyperlipidemia able to maintain a healthy diet and with blood cholesterol levels between 194 and 348 mg per dL were eligible for enrollment in the trial. A sample size of 120 patients (30 patients per group) was randomly assigned to one of four groups. Group A received krill oil at a body mass index (BMI)-dependent daily dosage of 2-3 g daily. Patients in Group B were given 1-1.5 g krill oil daily, and Group C was given fish oil containing 180 mg eicosapentaenoic acid (EPA) and 120 mg docosahexaenoic acid (DHA) per gram of oil at a dose of 3 g daily. Group D was given a placebo containing microcrystalline cellulose. The krill oil used in this study was Neptune Krill Oil, provided by Neptune Technologies and Bioresources, Laval, Quebec, Canada.

Outcome measures: Primary parameters tested (baseline and 90-day visit) were total blood cholesterol, triglycerides, LDL, HDL, and glucose.

Results: Krill oil 1-3 g per day (BMI-dependent) was found to be effective for the reduction of glucose, total cholesterol, triglycerides, LDL, and HDL, compared to both fish oil and placebo.

Conclusions: The results of the present study demonstrate within high levels of confidence that krill oil is effective for the management of hyperlipidemia by significantly reducing total cholesterol, LDL, and triglycerides, and increasing HDL levels. At lower and equal doses, krill oil was significantly more effective than fish oil for the reduction of glucose, triglycerides, and LDL levels.

PubMed Disclaimer

Cited by

Revolutionizing Diabetes Care: The Role of Marine Bioactive Compounds and Microorganisms.
Reddy KTK, Rakesh K, Prathyusha S, Gupta JK, Nagasree K, Lokeshvar R, Elumalai S, Prasad PD, Kolli D. Reddy KTK, et al. Cell Biochem Biophys. 2024 Sep 10. doi: 10.1007/s12013-024-01508-1. Online ahead of print. Cell Biochem Biophys. 2024. PMID: 39254792 Review.
Analysis of Fatty Acid Compositions and Acid Values of Krill Oil Supplementary Products from the Korean Market.
Lee JY, Hong JB, Kim BK, Shim SB, Jang HW, Lee JB. Lee JY, et al. J Microbiol Biotechnol. 2024 Oct 28;34(10):1988-1994. doi: 10.4014/jmb.2406.06026. Epub 2024 Aug 23. J Microbiol Biotechnol. 2024. PMID: 39233519 Free PMC article.
Krill oil inhibited adipogenic differentiation by inducing the nuclear Nrf2 expression and the AMPK activity.
Lee HJ, Seo JW, Chun YS, Kim J, Lim TG, Shim SM. Lee HJ, et al. Food Sci Nutr. 2023 Jul 21;11(10):6384-6392. doi: 10.1002/fsn3.3576. eCollection 2023 Oct. Food Sci Nutr. 2023. PMID: 37823164 Free PMC article.
The Prospective Associations of Egg Consumption with the Risk of Total Cerebrovascular Disease Morbidity among Chinese Adults.
Pan C, Sun X, Song J, Yu C, Guo Y, Wang S, Gao R, Ning F, Pang Z, Chen Z, Li L. Pan C, et al. Nutrients. 2023 Apr 7;15(8):1808. doi: 10.3390/nu15081808. Nutrients. 2023. PMID: 37111029 Free PMC article.
Lipid/Clay-Based Solid Dispersion Formulation for Improving the Oral Bioavailability of Curcumin.
Song JG, Noh HM, Lee SH, Han HK. Song JG, et al. Pharmaceutics. 2022 Oct 24;14(11):2269. doi: 10.3390/pharmaceutics14112269. Pharmaceutics. 2022. PMID: 36365088 Free PMC article.

Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia - PubMed (original) (raw)